mRNA Vaccines and Therapeutics Global Market Report 2023: Sector to Reach $66.2 Billion by 2028 at a 2.8% CAGR – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 66.2 Billion by 2028, exhibiting a CAGR … [Read more…]

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2023: Featuring Iovance, Candel Therapeutics & Replimune – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and … [Read more…]

Intelsat 40e Performing Well After Launch

WESTMINSTER, Colo.–(BUSINESS WIRE)–Maxar Technologies (NYSE:MAXR) (TSX:MAXR), provider of comprehensive space solutions and secure, precise, geospatial intelligence, today announced that Intelsat 40e (IS-40e) is performing as expected after being launched aboard a SpaceX Falcon 9 rocket from Cape Canaveral Space Force Station in Florida. Shortly after launch earlier today, the satellite deployed its solar arrays and … [Read more…]

2 Day Medical Device Regulatory Requirements and Adverse Event Reporting Training Course (May 25-26, 2023) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Medical Device Studies: Regulatory Requirements and Adverse Event Reporting Training Course” conference has been added to ResearchAndMarkets.com’s offering. This seminar provides an essential overview of medical device clinical evaluations, clinical investigations and PMCF studies with particular emphasis on the adverse event reporting requirements during these studies. The course will concentrate mostly on the … [Read more…]

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023

The Annual General Meeting will be broadcasted live by the Company MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) will hold its Annual General Meeting of Shareholders (“AGM”) at 10:30 a.m. CEST on May 12, 2023 in its headquarters, 117 avenue de Luminy, F-13009 Marseille. The Annual General Meeting … [Read more…]

IQVIA to Announce First-Quarter 2023 Results on April 27, 2023

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2023 financial results before the market opens on Thursday, April 27, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be … [Read more…]

Baxter to Host First-Quarter 2023 Financial Results Conference Call for Investors

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2023 financial results on Thursday, April 27, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/WhpPxesO to pre-register for the call and receive the call information. This call … [Read more…]

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

SAN JOSE, Calif.–(BUSINESS WIRE)–Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of February 28, 2023, were IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital. 1. IntraOp Medical Corp. is the manufacturer of … [Read more…]

Wellbeing Announces Cease Trade Order

  VANCOUVER, British Columbia–(BUSINESS WIRE)–$KONEF #psychedelics–Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2) announces that the British Columbia Securities Commission (the “BCSC”) has issued a Failure-to-File Cease Trade Order (“FFCTO”) pursuant to National Policy 11-207 – Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions dated, April … [Read more…]

AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023

VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) will announce its first quarter 2023 financial results on Thursday, May 4, 2023, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link that will be posted … [Read more…]